Prolonged COVID-19 in a Multiple Sclerosis Patient Treated With Rituximab.

Immunocompromised patients commonly present prolonged viral shedding of the novel coronavirus SARS-CoV-2, detected through reverse transcriptase-polymerase chain reaction (RT-PCR) in nasopharyngeal or oropharyngeal swabs. The detection and estimation of the viral load in patients with COVID-19 is of utmost importance, not only for the effective isolation of the patient but also from a therapeutic point of view. In the current study, we present the case of an immunocompromised patient receiving rituximab infusions for the treatment of multiple sclerosis who exhibited COVID-19 clinical symptomatology for an extended period of time along with prolonged viral shedding while at the same time being unable to organize sufficient humoral immunity.

Validation of the A&D UM-101 professional hybrid device for office blood pressure measurement according to the International Protocol.

Objective: Assessment of the accuracy of the A&D UM-101 mercury-free professional device for auscultatory blood pressure (BP) measurement according to the European Society of Hypertension International Protocol. Further to auscultation, the device has a button to mark readings during deflation.

Methods: Fifteen adults were included in phase 1 and another 18 in phase 2.

Validation of the Microlife WatchBP Home device for self home blood pressure measurement according to the International Protocol.

Objective: Current guidelines recommend that self monitoring of blood pressure at home should only be performed using validated devices. This study assessed the accuracy of the Microlife WatchBP Home device for self home blood pressure measurement according to the European Society of Hypertension International Protocol.

Methods: Thirty-three participants were included (15 in phase 1 and an additional 18 in phase 2).